Aurolab Trust

Aurolab Trust, established in July 1992, is a non-profit charitable trust headquartered in Madurai, Tamil Nadu, India. It operates as a medium-sized enterprise, focusing on the manufacturing of ophthalmic consumables, including intraocular lenses (IOLs), surgical sutures, and pharmaceutical products. The trust is an integral part of the Aravind Eye Care System, a globally recognized network dedicated to providing quality eye care.

The trust's mission is to make modern ophthalmic technologies affordable and accessible, particularly in developing countries. By engineering high-quality products at a fraction of the cost of imported alternatives, Aurolab Trust has significantly contributed to reducing needless blindness worldwide.

Aurolab Trust's manufacturing facility is located in Madurai, Tamil Nadu, India. The plant specializes in the production of ophthalmic consumables, including IOLs, surgical sutures, and pharmaceutical products. The facility adheres to stringent quality assurance measures, complying with US FDA, EU GMP, and WHO GMP norms, ensuring the production of high-quality products.

The leadership team at Aurolab Trust includes:

• Mr. R.D. Thulsiraj: President of Aurolab Trust and Director of Operations at the Aravind Eye Care System.

• Dr. S. Aravind: Secretary of Aurolab Trust and Director of Projects at the Aravind Eye Care System.

• Dr. P. Namperumalsamy: Trustee of Aurolab Trust and Chairman Emeritus of the Aravind Eye Care System.

• Dr. G. Natchiar: Trustee of Aurolab Trust and Director Emeritus of the Aravind Eye Care System.

• Dr. R. Kim: Trustee of Aurolab Trust and Director of IT & Technology at the Aravind Eye Care System.

• Dr. N. Venkatesh Prajna: Trustee of Aurolab Trust and Director of Finance at the Aravind Eye Care System.

Aurolab Trust's products are exported to over 150 countries, including the United States, European Union, United Kingdom, Australia, and Japan. The trust's manufacturing facilities comply with international standards, including US FDA, EU GMP, and WHO GMP norms, facilitating market access in these regulated regions. While specific regulatory filings and approvals are not publicly disclosed, the adherence to these standards indicates a commitment to meeting the requirements of these markets.

Aurolab Trust has a significant presence in emerging markets, particularly in Africa, Latin America, and Southeast Asia. The trust's products are exported to countries such as the Philippines, Indonesia, Uganda, Tanzania, Sri Lanka, Brazil, South Sudan, Zimbabwe, Bangladesh, Ivory Coast, Kenya, and Malawi. The trust's adherence to WHO GMP standards supports its ability to access these markets, as WHO prequalification is often a prerequisite for entry into many developing countries.

Aurolab Trust's geographic strategy focuses on diversifying its market presence across both developed and developing regions. By exporting to over 150 countries, the trust mitigates concentration risk and leverages opportunities in various markets. The emphasis on emerging markets aligns with the trust's mission to make quality eye care solutions accessible globally, particularly in regions with high unmet needs.

While specific details regarding FDA facility registrations, approved ANDAs, DMF filings, and inspection history are not publicly available, Aurolab Trust's compliance with US FDA standards indicates a commitment to meeting the regulatory requirements for the US market. The trust's adherence to international quality standards, including US FDA norms, supports its ability to export products to the United States.

Aurolab Trust's manufacturing facilities comply with WHO GMP standards, ensuring the production of high-quality ophthalmic consumables. This compliance facilitates market access in countries that require WHO prequalification for medical products. Additionally, the trust's adherence to EU GMP norms supports its ability to export products to European markets.

As a manufacturer based in India, Aurolab Trust operates under the regulations of the Central Drugs Standard Control Organisation (CDSCO). The trust's compliance with international quality standards, including WHO GMP, indicates adherence to CDSCO requirements for manufacturing and exporting pharmaceutical products.

Specific details regarding recent regulatory actions, such as Form 483 observations, warning letters, or import alerts, are not publicly available. However, Aurolab Trust's commitment to quality assurance and adherence to international standards suggests a proactive approach to regulatory compliance.

Aurolab Trust operates in a competitive landscape with several key players in the ophthalmic consumables market. Competitors include Appasamy Associates, Zeiss India, and Devine Meditech. While specific market share data is not publicly available, Aurolab Trust's extensive product portfolio and adherence to international quality standards position it as a significant player in the global market.

Aurolab Trust's key differentiators include its non-profit status, which allows for the provision of high-quality ophthalmic consumables at affordable prices, and its integration within the Aravind Eye Care System, a globally recognized network dedicated to quality eye care. The trust's commitment to innovation and adherence to international quality standards further distinguish it in the market.

Aurolab Trust's strategic direction focuses on providing affordable and accessible ophthalmic solutions globally. The trust's expansion into related healthcare areas, such as cardiovascular sutures and antiseptics, leverages existing capabilities and aligns with its mission to address a broader range of medical needs. The future outlook includes continued innovation and expansion into both developed and developing markets.

Aurolab Trust has a track record of consistent export volume, with shipments to over 150 countries, indicating reliability in meeting international demand. The trust's adherence to international quality standards, including US FDA, EU GMP, and WHO GMP norms, serves as reliability indicators, ensuring the production of high-quality ophthalmic consumables.

Importers should verify the following certifications to ensure product quality and compliance:

• FDA Registration: Confirm the facility's registration with the US FDA.

• WHO GMP Certification: Verify compliance with WHO Good Manufacturing Practices.

• EU GMP Certification: Ensure adherence to European Union Good Manufacturing Practices.

• ISO Certification: Check for relevant ISO certifications related to quality management systems.

These certifications can typically be verified through the issuing authorities' official websites or by contacting Aurolab Trust directly.

Importers should consider the following steps for due diligence:

• Verify Certifications: Confirm the authenticity of FDA, WHO GMP, EU GMP, and ISO certifications.

• Assess Compliance History: Review any past regulatory actions or compliance issues.

• Evaluate Product Quality: Request product samples and conduct quality assessments.

• Review Financial Stability: Analyze financial statements to assess the supplier's financial health.

• Check References: Obtain feedback from other clients or partners who have worked with Aurolab Trust.

Red flags to watch for include expired or unverifiable certifications, a history of regulatory violations, and inconsistent product quality. Recommended pre-order checks involve thorough verification of certifications, quality assessments, and financial evaluations to ensure a reliable and compliant partnership.